Bipolar Disorder Therapeutics Market Analysis

The market is segmented by drug type and by the mechanism of action. The antipsychotics sector of the drug type segment is anticipated to hold leading shares in the bipolar disorder therapeutics market on account of its suitability with SSRI as part of combination therapy, and demonstrating good results causing a significant number of physicians to opt for antipsychotics. On the contrary, Anticonvulsants constituted a moderate share in the market by serving as effective depression mood stabilizer by alleviating the depressive symptoms of bipolar disorder without precipitating mania, and by overcoming the limitations faced by traditional antidepressants as they stabilize the mood without triggering mania or causing episode acceleration. 

Our in-depth analysis of the global market includes the following segments